Showing results (1-10 of 145) with videos related to
Sort By:
Pageof 15
Statistics in Medicine|June 22, 2018
Dynamic development paths for expanding a proof-of-concept study to explore dose rangeQiqi Deng, Xiaofei Bai, Naitee TingTherapeutic Innovation & Regulatory Science|May 24, 2021
Proof of Concept: Drug Selection? Or Dose Selection? Thoughts on Multiplicity IssuesQian H Li, Qiqi Deng, Naitee TingStatistics in Medicine|June 11, 2025
Consistency-Based Approach to Adjust for Multiplicity in Confirmatory Subgroup AnalysisQiqi Deng, Qian Li, Naitee Ting, et al.Journal of Biopharmaceutical Statistics|June 26, 2019
Applying CHW method to 2-in-1 design: gain or lose?Xiaofei Bai, Qiqi DengJournal of Biopharmaceutical Statistics|September 29, 2020
Multiplicity issues for platform trials with a shared control armXiaofei Bai, Qiqi Deng, Dacheng LiuJournal of Biopharmaceutical Statistics|June 6, 2024
Conditional bias adjusted estimator of treatment effect in 2-in-1 adaptive designXiaofei Bai, Qiqi Deng, Wen LiStatistics in Medicine|March 16, 2021
Estimation of treatment effect in 2-in-1 adaptive design and some of its extensionsWen Li, Xiaofei Bai, Qiqi Deng, et al.Therapeutic Innovation & Regulatory Science|May 2, 2018
Statistical Interactions in a Clinical TrialNaitee TingFrontiers in Public Health|January 17, 2014
An Application of Graphical Approach to Construct Multiple Testing Procedures in a Hypothetical Phase III DesignBushi Wang, Naitee TingJournal of Biopharmaceutical Statistics|July 24, 2026
Why the minimum effective dose is unidentifiable - and how a DOR→OOD standard delivers label-ready dosing in oncologyHaitao Pan, Naitee TingPageof 15